KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Preferred Stock Liabilities (2019 - 2020)

GoodRx Holdings' Preferred Stock Liabilities history spans 2 years, with the latest figure at $737.0 million for Q2 2020.

  • For Q2 2020, Preferred Stock Liabilities changed N/A year-over-year to $737.0 million; the TTM value through Jun 2020 reached $737.0 million, changed N/A, while the annual FY2019 figure was $737.0 million, 0.0% changed from the prior year.
  • Preferred Stock Liabilities for Q2 2020 was $737.0 million at GoodRx Holdings, roughly flat from $737.0 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $737.0 million in Q3 2019 and bottomed at $737.0 million in Q3 2019.